| LncRNAs | Disease | Experimental methods | Regulated | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pubmed ID | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DLGAP1-AS1 | hepatocellular carcinoma | qRT-PCR, Western blot (WB) analysis, RIP, Luciferase reporter assay | H | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31949128 | 2020 |
| DLGAP1-AS1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, RIP | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 31633236 | 2019 |
| DLGAP1-AS1 | Colorectal cancer | RIP assay;RNA immunoprecipitation;Western blot;Flow Cytometry assay;RNA immunoprecipitation; | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 33816780 | 2021 |